MEDICAL NEWS TODAY (March 22, 2019)
During the 2019 Future Healthcare event in London, MobileODT was honored to present the EVA System during the Health Innovations Theatre. From over 350 brands that attended, MobileODT was featured in Medical News Today as one of the top six innovations from the event.
In 2018, globally, there were 570,000 new cases of cervical cancer. Around 90 percent of deaths from cervical cancer occur in low- and middle-income societies. Better screening and earlier intervention could significantly reduce the mortalty rate.
MobileODT have designed a battery-powered, hand-held colposcope called the EVA System, which can take high-quality images of the cervix. MobileODT worked with the National Cancer Institute to develop a machine learning algorithm, called automatic visual evaluation (AVE), that can produce an accurate diagnosis in minutes.
A prospective, multicenter pilot study that scientists conducted in Korea showed that the device is more than 90 percent accurate.
Yael Misrahi — head of global partnerships at MobileODT — outlined the product at Future Healthcare. MNT caught up with her after the event, and she explained that one of the primary benefits of this system is that “it is handheld and can be used by a nonexpert healthcare provider.”
Because the device is based on smartphone technology, it is user-friendly and includes a “remote consultation feature to consult experts either in real-time or during a quality assurance check.”
According to Misrahi, “[w]ith AVE — the machine learning algorithm for detection of pre-cancer — there is no need for a scrape or a lab and a woman is able to receive a result at the point of care rather than waiting several weeks or months for a result.”